Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease

Area of Science:

• Nephrology
• Biomarker Discovery
• Pediatric Research

Background:

• Chronic kidney disease (CKD) pathophysiology is complex, necessitating the exploration of diverse mechanistic pathways for novel biomarker development.
• Traditional biomarkers like glomerular filtration rate and proteinuria have limitations in accurately classifying and prognosing CKD progression.
• Recent advances in metabolomic and proteomic screening, coupled with a deeper understanding of CKD, have identified promising novel biomarkers.

Purpose of the Study:

• To review and highlight emerging biomarkers for predicting CKD progression in children.
• To emphasize the potential of these novel biomarkers as future prognostic tools in pediatric nephrology.
• To underscore the need for validation of these biomarkers for improved clinical management.

Main Methods:

• Review of recent literature on biomarker discovery in CKD.
• Analysis of metabolomic and proteomic screening studies.
• Synthesis of current knowledge on CKD pathophysiology and its relation to biomarkers.

Main Results:

• Identification of promising candidate proteins and metabolites associated with CKD progression in children.
• Highlighting biomarkers that could potentially serve as future prognostic markers.
• Discussion of the limitations of current biomarkers and the need for new ones.

Conclusions:

• Novel biomarkers hold significant promise for improving the clinical management of pediatric CKD.
• Further validation studies are essential to confirm the utility of candidate proteins and metabolites.
• Early identification of high-risk children through validated biomarkers can facilitate timely interventions and clinical trial enrollment.